Skip to content
ClinCalc Pro
Menu
Antibiotic — IV Penicillin Pregnancy: SPC §4.6: benzylpenicillin sodium has been taken by a large number of pregnant women and women of childbearing age without an increase in malformations or other direct or indirect harmful effects on the foetus having been observed. It is not known if it is excreted into human breast milk, but it is actively transported from blood to milk in animals and trace amounts of other penicillins have been detected in human milk.

Benzylpenicillin (Penicillin G)

Brand names: Crystapen

Benzylpenicillin (penicillin G) is a parenteral narrow-spectrum beta-lactam given by intravenous or intramuscular injection for serious streptococcal, meningococcal and other susceptible infections, including severe ENT and deep neck-space infections.

Auto-extracted from the source labelling — not yet independently clinician-verified. These values were distilled from the UK SPC (or the US label where noted) but have not had a clinician sign-off. Confirm against the current SmPC before prescribing.

Adult dose

Dose: 600 mg to 3,600 mg (1 to 6 mega units) daily
Route: Intramuscular or intravenous
Frequency: Daily total divided into 4 to 6 doses, depending on the indication
Max: Higher doses up to 14.4 g/day (24 mega units) in divided doses may be given by the intravenous route in serious infections such as adult meningitis; doses up to 43.2 g (72 mega units) per day may be necessary for patients with rapidly spreading gas gangrene
SPC §4.2. Other regimens stated: bacterial endocarditis — 7.2 to 12 g (12 to 20 mega units) or more daily in divided doses by the intravenous route, often by infusion. Meningococcal disease, adults and children over 12 years — 2.4 g every 4 hours. Suspected meningococcal disease (single pre-hospital dose given by the GP before transfer): adults and children over 10 years 1,200 mg IV or IM; children 1-9 years 600 mg IV or IM; children under 1 year 300 mg IV or IM. Prevention of Group B streptococcal disease of the newborn — a 3 g (5 mega units) loading dose to the mother initially, followed by 1.5 g (2.5 mega units) every 4 hours until delivery. ADMINISTRATION: the stated doses apply to both intramuscular and intravenous injection; alternate sites for repeated injections. High doses should be given by intravenous injection or infusion, with intravenous doses in excess of 1.2 g (2 mega units) given slowly, taking at least one minute for each 300 mg (0.5 mega unit), to avoid high levels causing irritation of the central nervous system and/or electrolyte imbalance. RECONSTITUTION (1200 mg vial): IV injection — dissolve in at least 8 mL Sodium Chloride Injection BP or Water for Injections BP; IV infusion — dissolve in at least 20 mL. Only freshly prepared solutions should be used; reconstituted solutions are intended for immediate administration. In renal failure and/or heart failure do not reconstitute in sodium-containing liquids such as Sodium Chloride Injection BP or Ringer's solution (sodium overload and/or heart failure may occur). High dosage may result in hypernatraemia and hypokalaemia unless the sodium content is taken into account. ELDERLY: elimination may be delayed and dose reduction may be necessary. SOURCE SCOPE: the SPC used is the general Benzylpenicillin sodium 1200 mg Powder for Injection label; it contains no ENT-specific posology, so dose is by indication and severity as above. SPC §4.5 (interactions) was truncated at the source-fetch limit and was not retrieved — interactions are therefore not recorded in this draft.

Paediatric dose

Dose: 100 mg/kg
Route: Intramuscular or intravenous
Frequency: 100 mg/kg/DAY (total daily dose, not a single dose) given in 4 divided doses — children aged 1 month to 12 years
Max: Not exceeding 4 g/day
SPC §4.2 age bands as stated: children 1 month to 12 years — 100 mg/kg/day in 4 divided doses, not exceeding 4 g/day; infants 1-4 weeks — 75 mg/kg/day in 3 divided doses; newborn infants — 50 mg/kg/day in 2 divided doses. MENINGOCOCCAL DISEASE: children 1 month to 12 years — 180-300 mg/kg/day in 4-6 divided doses, not exceeding 12 g/day; infants 1-4 weeks — 150 mg/kg/day in 3 divided doses; newborn infants — 100 mg/kg/day in 2 divided doses. SUSPECTED MENINGOCOCCAL DISEASE (single dose before transfer to hospital): children 1-9 years 600 mg IV or IM; children under 1 year 300 mg IV or IM. PREMATURE BABIES AND NEONATES: dosing should not be more frequent than every 8 or 12 hours in this age group, since renal clearance is reduced at this age and the mean half-life of benzylpenicillin may be as long as 3 hours; since infants have been found to develop severe local reactions to intramuscular injections, intravenous treatment should preferably be used. Verify all paediatric doses against a children's formulary before prescribing.

Dose adjustments

Renal

SPC §4.2. For doses of 0.6-1.2 g (1-2 mega units) the dosing interval should be no more frequent than every 8-10 hours. For high doses (e.g. 14.4 g / 24 mega units required for serious infections such as meningitis) adjust by creatinine clearance (mL/min), given as dose (g) / mega units / dosing interval (hours): CrCl 125 — 1.2 or 1.8 g (2 or 3 mega units), interval values given as '2 3'; CrCl 60 — 1.2 g (2 mega units) every 4 hours; CrCl 40 — 0.9 g (1.5 mega units) every 4 hours; CrCl 20 — 0.6 g (1.0 mega unit) every 4 hours; CrCl 10 — 0.6 g (1.0 mega unit) every 6 hours; CrCl nil — 0.3 or 0.6 g (0.5 or 1.0 mega unit), interval values given as '6 8'. CAUTION: the SPC table was flattened to plain text during fetch, so the pairing of the two dose options with the two interval values in the 'CrCl 125' and 'CrCl nil' rows is ambiguous — clinician to confirm against the original SPC table. The dose in that table should be further reduced to 300 mg (0.5 mega units) 8-hourly if advanced liver disease is associated with severe renal failure. If haemodialysis is required, an additional dose of 300 mg (0.5 mega units) should be given 6-hourly during the procedure.

Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.

Paediatric weight-based calculator

SPC §4.2 age bands as stated: children 1 month to 12 years — 100 mg/kg/day in 4 divided doses, not exceeding 4 g/day; infants 1-4 weeks — 75 mg/kg/day in 3 divided doses; newborn infants — 50 mg/kg/day in 2 divided doses. MENINGOCOCCAL DISEASE: children 1 month to 12 years — 180-300 mg/kg/day in 4-6 divided doses, not exceeding 12 g/day; infants 1-4 weeks — 150 mg/kg/day in 3 divided doses; newborn infants — 100 mg/kg/day in 2 divided doses. SUSPECTED MENINGOCOCCAL DISEASE (single dose before transfer to hospital): children 1-9 years 600 mg IV or IM; children under 1 year 300 mg IV or IM. PREMATURE BABIES AND NEONATES: dosing should not be more frequent than every 8 or 12 hours in this age group, since renal clearance is reduced at this age and the mean half-life of benzylpenicillin may be as long as 3 hours; since infants have been found to develop severe local reactions to intramuscular injections, intravenous treatment should preferably be used. Verify all paediatric doses against a children's formulary before prescribing.

Verify in a children's formulary

Contraindications

  • Allergy to penicillins
  • Hypersensitivity to any ingredient of the preparation
  • Cross-allergy to other beta-lactams such as cephalosporins should be taken into account

Side effects

  • Hypersensitivity to penicillin in the form of rashes (all types), fever and serum sickness — common (1-10% of treated patients)
  • Jarisch-Herxheimer reaction in patients treated for syphilis or neurosyphilis — very common (>10%)
  • Anaphylactic reactions — rare (<0.05% of treated patients); angioedema — frequency not known
  • Granulocytopenia (neutropenia), agranulocytosis and leucopenia in patients receiving prolonged high doses — rare (0.01-0.1%)
  • Central nervous system toxicity including convulsions, reported with massive doses over 60 g per day and in patients with severe renal impairment — rare
  • Interstitial nephritis reported after intravenous benzylpenicillin sodium at doses of more than 12 g per day — rare; and Clostridium difficile diarrhoea

Clinical monograph

How it works

It inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins, and is bactericidal against susceptible Gram-positive cocci such as group A streptococci.

Prescribing in practice

  • Contraindicated in patients with previous immediate hypersensitivity to penicillins; check allergy status carefully and have anaphylaxis management available, as serious reactions can occur with parenteral dosing.
  • It is acid-labile and not absorbed orally, so it must be given by injection; doses are reduced in significant renal impairment because it is renally cleared.
  • Very high parenteral doses contribute a notable sodium and potassium load and have rarely been associated with neurotoxicity (seizures), particularly in renal impairment.

Monitoring

Monitor renal function, electrolytes and clinical response, and observe for hypersensitivity, especially after the first parenteral dose.

Counselling the patient

  • Tell staff at once about any rash, swelling, wheeze or faintness during or after the injection.
  • Report any previous reaction to penicillin or other antibiotics before treatment.
  • Complete the full prescribed course as directed.

Evidence & guidelines

Penicillin G remains a first-line agent for invasive group A streptococcal and meningococcal disease in national antimicrobial and infection guidance.

Reference: NICE NG84; ENT-UK Mastoiditis Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.